Fundació HiTT arose from a desire to help build a brighter future for healthcare. We strongly believe that innovation, co-creation, and entrepreneurship are necessary to build a sustainable healthcare system – and we’re committed to making it happen.
OUR ACTIVIES
NEWS
AES Health Economics Conference
Health Economics Conference – AES The XL+1 edition of the Health Economics Conference, organized by the AES Health Economics Association, has taken place in Zaragoza on June 15 to 17. We have taken part of this event exploring issues such as: medical care decision-making, economic assessment, the management of healthcare institutions and the investment in
-> Continue reading AES Health Economics Conference
WORLD MULTIPLE SCLEROSIS DAY
Multiple Sclerosis is a chronic disease that currently affects around 55,000 people in Spain and gathers 1,800 new diagnoses each year. World Multiple Sclerosis Day raises awareness of a complex, cross-cutting disease that involves healthcare, psychological and social issues. Aimed by the twofold goal of meeting the needs of people with Multiple Sclerosis and optimizing
-> Continue reading WORLD MULTIPLE SCLEROSIS DAY
CLINICAL TRIALS DAY
Clinical trials have traditionally been the quintessential clinical research tool, responsible for driving many of the scientific advances made in the field of health and the historical transformations that have taken place in terms of hope and life quality. May 20th, the International Clinical Trial Day, becomes an opportunity to highlight the work of those
-> Continue reading CLINICAL TRIALS DAY
CASSANDRA PROJECT FOR LUNG CANCER EARLY DETECTION
Lung cancer is a growing issue worldwide. It currently ranks as the cancer with the highest number of cases detected, and it is responsible for the highest number of cancer deaths on a global scale. By 2024, it is estimated to be the cause of 3 million new cancers. In Spain, lung cancer is the
-> Continue reading CASSANDRA PROJECT FOR LUNG CANCER EARLY DETECTION
CASE STUDY: PROJECT AGAINST GENDER VIOLENCE
THE PROJECT In collaboration with the Catalan Agency for Health Quality and Assessment (AQuAS), Fundació HiTT carried out a project for the reformulation of the protocol, approved by the Department of Health of Catalonia in 2009, for the correct detection and treatment of women and children victims of gender-based violence. The study aimed to assess
-> Continue reading CASE STUDY: PROJECT AGAINST GENDER VIOLENCE
FUNADCIÓ HiTT 2ND ANNIVERSARI
Fundació HiTT went public on a day like today in 2019. While we were getting closer to days of celebration, we had one more reason to be happy: the birth of the HiTT Foundation. Happiness that today we remember one more time seeing, on its second anniversary, the progress it has made. After years of
-> Continue reading FUNADCIÓ HiTT 2ND ANNIVERSARI
#25N “International Day for the Elimination of Violence against Women”
Violence against women represents a cross-cutting and multidimensional problem that has been classified as a health problem by WHO. Due to its complexity, it is a phenomenon that needs to be addressed through a cross-sectional perspective, involving different sectors of society to provide a coordinated response to the phenomenon. A few months ago Fundació HiTT
-> Continue reading #25N “International Day for the Elimination of Violence against Women”
III fHorum – Chronicity
The third edition of the fHorum took place yesterday. It is organized by Fundació HiTT, with the support, one more year, of Novartis. Despite the complicated situation that the pandemic leaves us, we are glad to go forward with this project. A project aimed at creating shared knowledge through the meeting of different experts in
-> Continue reading III fHorum – Chronicity
Promoting Innovative Projects
HiTT Foundation was created with the aim of promoting change in the current healthcare paradigm and generating a positive impact on the health System. We believe that the key to change can be found in the combination of innovation and entrepreneurship. These are the cornerstones on which we must build the future health system, a
-> Continue reading Promoting Innovative Projects
World Orphan Drugs Congress 2021
World Orphan Drugs Congress 2021 is taking place this week in Sitges. WODC offers an approach to the whole orphan drug situation. It has become, trough the editions, the largest and most established European event in this field. In this 12th edition, the annual event will gather experts from the whole value chain in the
-> Continue reading World Orphan Drugs Congress 2021
CaixaResearch Validate Training 2021
CaixaResearch Validate Training 2021 is coming to an end. Today, our colleagues have attended the last session of Specialized Training organized by Caixa Research. CaixaResearch Validate is the result of the willing to transfer research to market and society. Providing resources to early stage biomedical research projects to help them become a reality. It provides
-> Continue reading CaixaResearch Validate Training 2021
BIZBARCELONA 2021
BizBarcelona has been celebrated this week, from 9 to 11 of November in Fira de Monjuïc. It has brought together both companies and talent in the same spot of Barcelona. BizBarcelona is a benchmark event in the matter of entrepreneurship. It is an opportunity for companies to reinvent themselves and to start innovative projects. Exploring
-> Continue reading BIZBARCELONA 2021
fHorum 3rd Edition
We are glad to finally announce that the 3rd edition of fHoum will take place on November 22nd. fHorum stems from the need to address key issues of the biomedical field. Exchanging ideas with the aim of generating innovative proposals, willing to improve the medical sector. The issues that we will be addressing have lately become
-> Continue reading fHorum 3rd Edition
We keep growing!
Our project is growing, therefore and to incorporate young talents with desire to work into our team, we have signed an agreement with the Pompeu Fabra University and we are very happy to introduce you to Clàudia Faura Colom, who joins the HiTT Foundation, to give support and contribute new ideas to our project in
-> Continue reading We keep growing!
Data Governance as an Enabler of RWD
Today we are presenting at #DIAconference our perspective on RWD and how payers would benefit from a well-defined and traceable Data Governance Plan to make RWD more trustworthy. Despite most of the focus is on methodologies and the validity of the data, it is important to build around the data collection a process that makes
-> Continue reading Data Governance as an Enabler of RWD
eHealth: a key contributor towards the sustainability of the healthcare system
The Covid-19 pandemic has accelerated a process that was already underway: the digital transformation in healthcare. From telemedicine and the remote monitoring and treatment of patients to artificial intelligence (AI)-enabled medical devices, healthcare digitalisation has the potential to improve healthcare delivery, enhance patients’ engagement and lower healthcare costs, all of which essential for achieving universal
-> Continue reading eHealth: a key contributor towards the sustainability of the healthcare system
Enlighted by SOPHIA’s world
In the midst of COVID lock-down I was asked to be part of this fantastic project #SOPHIA, looking at making a difference in the world of #obesity. I have / Fundació HiTT has the immense pleasure of being part of it and attending (yes, it moved last minute to virtual!) yesterday as a reimbursement advisor the general
-> Continue reading Enlighted by SOPHIA’s world
Taller Valor Compartit
Fantastic session with Roots for Sustainability, ACCIÓ and CataloniaBio & HealthTech expanding knowledge about business sustainability and how to generate shared value in our organizations.
New talent joining the team!!
We are very happy to announce that Monika is joining the HiTT Foundation. She brings a solid scientific and drug discovery career, enthusiasm and capacity
A NEW THERAPY AGAINST AGGRESSIVE TUMOURS
Fundació HiTT (FHiTT) is developing a new targeted therapy to treat aggressive cancers. This treatment, unlike the current highly toxic and unspecific options available, will offer increased efficacy and reduce side-effects, enhancing the life expectancy and well-being of cancer patients.